Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estuaries | 1 | 2021 | 1 | 0.700 |
Why?
|
| Cyanobacteria | 1 | 2021 | 10 | 0.690 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2025 | 18 | 0.230 |
Why?
|
| Salinity | 1 | 2021 | 3 | 0.170 |
Why?
|
| Fresh Water | 1 | 2021 | 16 | 0.170 |
Why?
|
| Aneuploidy | 1 | 2021 | 141 | 0.170 |
Why?
|
| Environmental Monitoring | 1 | 2021 | 105 | 0.160 |
Why?
|
| India | 1 | 2021 | 245 | 0.160 |
Why?
|
| Knowledge Bases | 1 | 2020 | 40 | 0.160 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2020 | 28 | 0.160 |
Why?
|
| Data Mining | 1 | 2020 | 67 | 0.150 |
Why?
|
| Seasons | 1 | 2021 | 338 | 0.150 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2025 | 627 | 0.150 |
Why?
|
| Software | 2 | 2025 | 754 | 0.150 |
Why?
|
| Phenotype | 2 | 2025 | 4550 | 0.140 |
Why?
|
| Leptin | 1 | 2020 | 218 | 0.140 |
Why?
|
| Databases, Genetic | 1 | 2020 | 504 | 0.130 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 233 | 0.130 |
Why?
|
| Biomarkers, Tumor | 2 | 2022 | 1624 | 0.110 |
Why?
|
| Computational Biology | 1 | 2020 | 875 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 934 | 0.110 |
Why?
|
| Oligodendroglia | 1 | 1994 | 83 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2021 | 910 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 1011 | 0.100 |
Why?
|
| Biological Ontologies | 2 | 2025 | 9 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 1408 | 0.090 |
Why?
|
| Neuronal Plasticity | 1 | 1994 | 298 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3439 | 0.070 |
Why?
|
| Drug Delivery Systems | 2 | 1999 | 215 | 0.070 |
Why?
|
| Spinal Cord | 2 | 1999 | 270 | 0.060 |
Why?
|
| Neoplasms | 1 | 2020 | 2968 | 0.060 |
Why?
|
| Language | 1 | 2025 | 227 | 0.050 |
Why?
|
| Glycomics | 1 | 2022 | 16 | 0.050 |
Why?
|
| Albumins | 2 | 1999 | 90 | 0.040 |
Why?
|
| Sex Chromosomes | 1 | 2021 | 30 | 0.040 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2021 | 62 | 0.040 |
Why?
|
| Schizophrenia, Childhood | 1 | 2001 | 1 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2022 | 143 | 0.040 |
Why?
|
| Alleles | 1 | 2025 | 1709 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2025 | 856 | 0.040 |
Why?
|
| Quinolinic Acid | 1 | 1999 | 10 | 0.040 |
Why?
|
| Globus Pallidus | 1 | 1999 | 68 | 0.040 |
Why?
|
| Antiparkinson Agents | 1 | 1999 | 65 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2020 | 164 | 0.040 |
Why?
|
| Serum Albumin | 1 | 1998 | 102 | 0.040 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2001 | 243 | 0.040 |
Why?
|
| Brain Diseases | 1 | 2001 | 305 | 0.040 |
Why?
|
| Humans | 8 | 2025 | 132158 | 0.030 |
Why?
|
| Endothelial Growth Factors | 1 | 1997 | 41 | 0.030 |
Why?
|
| Lymphokines | 1 | 1997 | 64 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4692 | 0.030 |
Why?
|
| Animals | 6 | 2025 | 34288 | 0.030 |
Why?
|
| Cognition | 1 | 2021 | 849 | 0.030 |
Why?
|
| Spinal Cord Injuries | 1 | 1999 | 279 | 0.030 |
Why?
|
| Proteolipids | 1 | 1994 | 6 | 0.030 |
Why?
|
| Myelin Basic Protein | 1 | 1994 | 68 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1994 | 87 | 0.030 |
Why?
|
| Child | 3 | 2025 | 26383 | 0.030 |
Why?
|
| Growth Substances | 1 | 1994 | 102 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 1994 | 237 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1994 | 452 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2020 | 1107 | 0.020 |
Why?
|
| Biomarkers | 1 | 2022 | 3426 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 1999 | 737 | 0.020 |
Why?
|
| Brain Injuries | 1 | 1997 | 712 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2001 | 3939 | 0.020 |
Why?
|
| Adolescent | 3 | 2021 | 21018 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2020 | 15103 | 0.020 |
Why?
|
| Base Sequence | 1 | 1994 | 2784 | 0.020 |
Why?
|
| Gene Expression | 1 | 1994 | 1508 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1994 | 3532 | 0.020 |
Why?
|
| Stem Cells | 1 | 1994 | 715 | 0.020 |
Why?
|
| Neurons | 1 | 1999 | 2009 | 0.020 |
Why?
|
| Autoradiography | 2 | 1999 | 65 | 0.020 |
Why?
|
| Carbon Radioisotopes | 2 | 1999 | 68 | 0.020 |
Why?
|
| DNA | 1 | 1994 | 1441 | 0.020 |
Why?
|
| Radionuclide Imaging | 2 | 1999 | 120 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 1994 | 2947 | 0.020 |
Why?
|
| Male | 3 | 2025 | 65464 | 0.020 |
Why?
|
| Macaca mulatta | 2 | 1999 | 497 | 0.020 |
Why?
|
| Adult | 2 | 2021 | 31755 | 0.020 |
Why?
|
| Female | 3 | 2025 | 71430 | 0.020 |
Why?
|
| Epilepsy | 1 | 1994 | 899 | 0.020 |
Why?
|
| Infant | 1 | 2020 | 13355 | 0.010 |
Why?
|
| Mice | 1 | 2020 | 18397 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 1999 | 2994 | 0.010 |
Why?
|
| Rats | 2 | 1999 | 3459 | 0.010 |
Why?
|
| Reference Values | 1 | 2001 | 693 | 0.010 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1999 | 9 | 0.010 |
Why?
|
| Dopamine Agents | 1 | 1999 | 28 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1999 | 81 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1999 | 80 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2001 | 391 | 0.010 |
Why?
|
| Swine, Miniature | 1 | 1998 | 55 | 0.010 |
Why?
|
| Silicon Dioxide | 1 | 1998 | 31 | 0.010 |
Why?
|
| Spinal Cord Diseases | 1 | 1998 | 34 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1998 | 131 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1998 | 197 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1998 | 367 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2001 | 467 | 0.010 |
Why?
|
| Gadolinium | 1 | 1998 | 112 | 0.010 |
Why?
|
| Safety | 1 | 1998 | 216 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 1998 | 166 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1997 | 49 | 0.010 |
Why?
|
| Gliosis | 1 | 1997 | 33 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1997 | 99 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1997 | 162 | 0.010 |
Why?
|
| Catheterization | 1 | 1998 | 234 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1997 | 104 | 0.010 |
Why?
|
| Radiography | 1 | 1999 | 761 | 0.010 |
Why?
|
| Equipment Design | 1 | 1998 | 557 | 0.010 |
Why?
|
| Motor Activity | 1 | 1999 | 506 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1999 | 839 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 1146 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 1997 | 344 | 0.010 |
Why?
|
| Swine | 1 | 1998 | 1188 | 0.010 |
Why?
|
| Contrast Media | 1 | 1998 | 493 | 0.010 |
Why?
|
| Astrocytes | 1 | 1997 | 288 | 0.010 |
Why?
|
| Middle Aged | 1 | 1994 | 28939 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 1614 | 0.010 |
Why?
|
| Brain | 1 | 2001 | 3253 | 0.000 |
Why?
|